126 GENES FOUND
Show / hide columns
XML |
RDF |
TSV |
« prev | Page next »
GLRA3 Glycine receptor, alpha 3 FDA approved drug targets Group enriched
GLRB Glycine receptor, beta Disease related genes Tissue enhanced
GNRHR Gonadotropin-releasing hormone receptor Disease related genes Tissue enhanced
GRIN1 Glutamate receptor, ionotropic, N-methyl D-aspartate 1 Disease related genes Tissue enriched
GRIN2C Glutamate receptor, ionotropic, N-methyl D-aspartate 2C FDA approved drug targets Tissue enhanced
HMGCR 3-hydroxy-3-methylglutaryl-CoA reductase Enzymes Expressed in all
HTR1B 5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled FDA approved drug targets Plasma membrane Tissue enhanced
HTR2B 5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled FDA approved drug targets Nucleoplasm Tissue enhanced
HTR3A 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic FDA approved drug targets Group enriched
ITGB1 Integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) Cancer-related genes Endoplasmic reticulum Expressed in all
KCNA2 Potassium channel, voltage gated shaker related subfamily A, member 2 Disease related genes Tissue enriched
KCNA3 Potassium channel, voltage gated shaker related subfamily A, member 3 FDA approved drug targets Mixed
KCNA5 Potassium channel, voltage gated shaker related subfamily A, member 5 Disease related genes Tissue enhanced
KCNB1 Potassium channel, voltage gated Shab related subfamily B, member 1 Disease related genes Tissue enhanced
KCNC3 Potassium channel, voltage gated Shaw related subfamily C, member 3 Disease related genes Tissue enhanced
KCND2 Potassium channel, voltage gated Shal related subfamily D, member 2 Disease related genes Tissue enhanced
KCND3 Potassium channel, voltage gated Shal related subfamily D, member 3 Disease related genes Mixed
KCNH2 Potassium channel, voltage gated eag related subfamily H, member 2 Disease related genes Tissue enhanced
KCNJ1 Potassium channel, inwardly rectifying subfamily J, member 1 Disease related genes Tissue enriched
KCNJ8 Potassium channel, inwardly rectifying subfamily J, member 8 Disease related genes Mixed
KCNK3 Potassium channel, two pore domain subfamily K, member 3 Disease related genes Tissue enhanced
KCNK9 Potassium channel, two pore domain subfamily K, member 9 Disease related genes Group enriched
KCNN4 Potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4 Disease related genes Tissue enhanced
KCNQ1 Potassium channel, voltage gated KQT-like subfamily Q, member 1 Disease related genes Tissue enhanced
KCNQ2 Potassium channel, voltage gated KQT-like subfamily Q, member 2 Disease related genes Endoplasmic reticulum Tissue enriched
KCNQ3 Potassium channel, voltage gated KQT-like subfamily Q, member 3 Disease related genes Tissue enriched
MC2R Melanocortin 2 receptor (adrenocorticotropic hormone) Disease related genes Tissue enriched
MS4A1 Membrane-spanning 4-domains, subfamily A, member 1 CD markers Group enriched
MTNR1A Melatonin receptor 1A FDA approved drug targets Tissue enhanced
PTGER1 Prostaglandin E receptor 1 (subtype EP1), 42kDa FDA approved drug targets Tissue enhanced
RYR1 Ryanodine receptor 1 (skeletal) Disease related genes Golgi apparatus Tissue enriched
SCN11A Sodium channel, voltage gated, type XI alpha subunit Disease related genes Tissue enhanced
SCN1A Sodium channel, voltage gated, type I alpha subunit Disease related genes Nucleoplasm Tissue enhanced
SCN2A Sodium channel, voltage gated, type II alpha subunit Disease related genes Tissue enriched
SCN2B Sodium channel, voltage gated, type II beta subunit Disease related genes Tissue enriched
SCN4A Sodium channel, voltage gated, type IV alpha subunit Disease related genes Nucleoplasm Group enriched
SCN4B Sodium channel, voltage gated, type IV beta subunit Disease related genes Tissue enhanced
SCN5A Sodium channel, voltage gated, type V alpha subunit Disease related genes Tissue enriched
SCN9A Sodium channel, voltage gated, type IX alpha subunit Disease related genes Plasma membrane Tissue enhanced
SCNN1A Sodium channel, non voltage gated 1 alpha subunit Disease related genes Mixed
SCNN1B Sodium channel, non voltage gated 1 beta subunit Disease related genes Tissue enhanced
SCNN1D Sodium channel, non voltage gated 1 delta subunit FDA approved drug targets Plasma membrane Tissue enhanced
SCNN1G Sodium channel, non voltage gated 1 gamma subunit Disease related genes Nucleoplasm Tissue enhanced
SCTR Secretin receptor FDA approved drug targets Tissue enhanced
SIGMAR1 Sigma non-opioid intracellular receptor 1 Disease related genes Expressed in all
SLC12A1 Solute carrier family 12 (sodium/potassium/chloride transporter), member 1 Disease related genes Tissue enriched
SLC12A2 Solute carrier family 12 (sodium/potassium/chloride transporter), member 2 FDA approved drug targets Vesicles Expressed in all
SLC12A3 Solute carrier family 12 (sodium/chloride transporter), member 3 Disease related genes Tissue enriched
SLC12A4 Solute carrier family 12 (potassium/chloride transporter), member 4 FDA approved drug targets Endosomes Expressed in all
SLC12A5 Solute carrier family 12 (potassium/chloride transporter), member 5 FDA approved drug targets Tissue enriched
« prev | Page next »
